VVOS

VVOS

USD

Vivos Therapeutics Inc. Common Stock

$2.630-0.010 (-0.379%)

Echtzeitkurs

Healthcare
Medizinprodukte
Vereinigte Staaten

Kursdiagramm

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$2.640

Hoch

$2.660

Tief

$2.554

Volumen

0.00M

Unternehmensfundamentaldaten

Marktkapitalisierung

16.0M

Branche

Medizinprodukte

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

0.12M

Börse

NCM

Währung

USD

52-Wochen-Spanne

Tief $1.91Aktuell $2.630Hoch $6.28

Ähnliche Nachrichten

GlobeNewswire

Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada

By acquiring The Sleep Center of Nevada, Vivos expands its business model to make its OSA treatments available to thousands of patients in the greater Las Vegas metro area Acquisition expected to close later this

Mehr anzeigen
Vivos Therapeutics Signs Definitive Agreement to  Acquire Largest Sleep Center Operator in Nevada
Analyst Upgrades

Ascendiant Capital Maintains Buy on Vivos Therapeutics, Lowers Price Target to $6.2

Ascendiant Capital analyst Lucas Ward maintains Vivos Therapeutics with a Buy and lowers the price target from $6.6 to $6.2.

Mehr anzeigen
Ascendiant Capital Maintains Buy on Vivos Therapeutics, Lowers Price Target to $6.2
GlobeNewswire

Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update

Year over year product revenue increased 26% Operating expenses declined 21% and year over year operating loss decreased 35% Management to Host Conference Call today at 5:00 pm ET LITTLETON, Colo., March 31,

Mehr anzeigen
Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update
GlobeNewswire

Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call

LITTLETON, Colo., March 28, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ:VVOS), a leading medical device and technology company specializing in the development and

Mehr anzeigen
Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call

Bleiben Sie auf dem Laufenden

Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.